These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9627940)

  • 1. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.
    Oseroff C; Sette A; Wentworth P; Celis E; Maewal A; Dahlberg C; Fikes J; Kubo RT; Chesnut RW; Grey HM; Alexander J
    Vaccine; 1998 May; 16(8):823-33. PubMed ID: 9627940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.
    Livingston BD; Crimi C; Grey H; Ishioka G; Chisari FV; Fikes J; Grey H; Chesnut RW; Sette A
    J Immunol; 1997 Aug; 159(3):1383-92. PubMed ID: 9233635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
    Shirai M; Chen M; Arichi T; Masaki T; Nishioka M; Newman M; Nakazawa T; Feinstone SM; Berzofsky JA
    J Infect Dis; 1996 Jan; 173(1):24-31. PubMed ID: 8537666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study.
    Le Gal FA; Prevost-Blondel A; Lengagne R; Bossus M; Farace F; Chaboissier A; Gras-Masse H; Engelhard VH; Guillet JG; Gahéry-Ségard H
    Int J Cancer; 2002 Mar; 98(2):221-7. PubMed ID: 11857412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus.
    Hiranuma K; Tamaki S; Nishimura Y; Kusuki S; Isogawa M; Kim G; Kaito M; Kuribayashi K; Adachi Y; Yasutomi Y
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():187-193. PubMed ID: 9934701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The optimization of helper T lymphocyte (HTL) function in vaccine development.
    Alexander J; Fikes J; Hoffman S; Franke E; Sacci J; Appella E; Chisari FV; Guidotti LG; Chesnut RW; Livingston B; Sette A
    Immunol Res; 1998; 18(2):79-92. PubMed ID: 9844827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.
    BenMohamed L; Krishnan R; Longmate J; Auge C; Low L; Primus J; Diamond DJ
    Hum Immunol; 2000 Aug; 61(8):764-79. PubMed ID: 10980387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.
    Depla E; Van der Aa A; Livingston BD; Crimi C; Allosery K; De Brabandere V; Krakover J; Murthy S; Huang M; Power S; Babé L; Dahlberg C; McKinney D; Sette A; Southwood S; Philip R; Newman MJ; Meheus L
    J Virol; 2008 Jan; 82(1):435-50. PubMed ID: 17942551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery.
    Alexander J; Oseroff C; Dahlberg C; Qin M; Ishioka G; Beebe M; Fikes J; Newman M; Chesnut RW; Morton PA; Fok K; Appella E; Sette A
    J Immunol; 2002 Jun; 168(12):6189-98. PubMed ID: 12055232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
    J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling to the surface of liposomes alters the immunogenicity of hepatitis C virus-derived peptides and confers sterile immunity.
    Takagi A; Kobayashi N; Taneichi M; Uchida T; Akatsuka T
    Biochem Biophys Res Commun; 2013 Jan; 430(1):183-9. PubMed ID: 23159619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization.
    Loirat D; Lemonnier FA; Michel ML
    J Immunol; 2000 Oct; 165(8):4748-55. PubMed ID: 11035120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse.
    Shao HY; Lin YW; Yu SL; Lin HY; Chitra E; Chang YC; Sia C; Chong P; Hsu MT; Wei OL; Chow YH
    PLoS One; 2011; 6(9):e25500. PubMed ID: 21980478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.
    Chung MK; Yoon H; Min SS; Lee HG; Kim YJ; Lee TG; Lim JS; Kim CM; Park SN
    J Immunother; 1999 Jul; 22(4):279-87. PubMed ID: 10404429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural requirements for synthetic immunogens to induce measles virus specific CTL responses.
    Partidos CD; Delmas A; Steward MW
    Mol Immunol; 1996 Nov; 33(16):1223-9. PubMed ID: 9129158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
    Zhu F; Eckels DD
    Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.
    Wentworth PA; Sette A; Celis E; Sidney J; Southwood S; Crimi C; Stitely S; Keogh E; Wong NC; Livingston B; Alazard D; Vitiello A; Grey HM; Chisari FV; Chesnut RW; Fikes J
    Int Immunol; 1996 May; 8(5):651-9. PubMed ID: 8671652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice.
    Lin SI; Huang MH; Chang YW; Chen IH; Roffler S; Chen BM; Sher YP; Liu SJ
    Cancer Lett; 2016 Jul; 377(2):126-33. PubMed ID: 27130449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
    Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
    Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.